Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C038983 |
1,3-dimethylthiourea |
1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of MSR1 mRNA | affects expression | 17562736
|
C056165 |
acetovanillone |
acetovanillone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
C061133 |
Am 80 |
Am 80 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 16484594
|
C061133 |
Am 80 |
Am 80 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 16484594
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of MSR1 mRNA | decreases expression | 20458559
|
C042138 |
BCG lipopolysaccharide |
BCG lipopolysaccharide results in increased expression of MSR1 mRNA | increases expression | 10223745
|
D020122 |
tert-Butylhydroperoxide |
MSR1 protein results in decreased susceptibility to tert-Butylhydroperoxide | decreases response to substance | 12763022
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased activity of MSR1 protein | decreases activity | 12763022
|
D002330 |
Carmustine |
Carmustine results in decreased expression of MSR1 mRNA | decreases expression | 15980968
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D003676 |
Deferoxamine |
Deferoxamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MSR1 mRNA | affects cotreatment|increases expression | 17942748
|
C460864 |
FSL-1 lipoprotein, synthetic |
FSL-1 lipoprotein, synthetic results in increased expression of MSR1 mRNA | increases expression | 17938187
|
C460864 |
FSL-1 lipoprotein, synthetic |
resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 17938187
|
D005665 |
Furosemide |
Furosemide results in increased expression of MSR1 mRNA | increases expression | 16526316
|
D017665 |
Hydroxyl Radical |
Hydroxyl Radical results in decreased degradation of MSR1 mRNA | decreases degradation | 9614211
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of MSR1 protein | increases expression | 10223745
|
C443401 |
quercetin 3-O-glucuronide |
quercetin 3-O-glucuronide results in decreased expression of MSR1 mRNA | decreases expression | 18199750
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 17938187
|
C059514 |
resveratrol |
resveratrol results in decreased expression of MSR1 mRNA | decreases expression | 16901463
|
D012402 |
Rotenone |
Rotenone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D020160 |
Sodium Benzoate |
Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D020160 |
Sodium Benzoate |
Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form] | decreases reaction|increases expression | 9614211
|
C003959 |
TEMPO |
TEMPO inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
C003959 |
TEMPO |
TEMPO inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form] | decreases reaction|increases expression | 9614211
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MSR1 mRNA | affects cotreatment|increases expression | 17942748
|
D013755 |
Tetradecanoylphorbol Acetate |
1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D013755 |
Tetradecanoylphorbol Acetate |
acetovanillone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D013755 |
Tetradecanoylphorbol Acetate |
Am 80 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 16484594
|
D013755 |
Tetradecanoylphorbol Acetate |
Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D013755 |
Tetradecanoylphorbol Acetate |
Deferoxamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D013755 |
Tetradecanoylphorbol Acetate |
Rotenone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D013755 |
Tetradecanoylphorbol Acetate |
Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D013755 |
Tetradecanoylphorbol Acetate |
Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form] | decreases reaction|increases expression | 9614211
|
D013755 |
Tetradecanoylphorbol Acetate |
TEMPO inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 9614211
|
D013755 |
Tetradecanoylphorbol Acetate |
TEMPO inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form] | decreases reaction|increases expression | 9614211
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA | increases expression | 9614211 16484594
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form | increases expression | 9614211
|
D013755 |
Tetradecanoylphorbol Acetate |
Am 80 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] | decreases reaction|increases expression | 16484594
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA | increases expression | 16484594
|
D015054 |
Zymosan |
Zymosan results in increased expression of MSR1 mRNA | increases expression | 10223745
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.70 | 11752688 15322242 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.79 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.71 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.89 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.16 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.16 | 14692618 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.23 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.54 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.55 | 11748828 |
MESH:D000740 |
Anemia |
|
Zymosan |
8.55 | 18664788 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.69 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.31 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
11.88 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
11.88 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
11.88 | 15944321 15142272 17659584 16872482 15188379 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Am 80 |
3.72 | 16819260 |
MESH:D050197 |
Atherosclerosis |
|
Am 80 |
11.02 | 16484594 |
MESH:D050197 |
Atherosclerosis |
|
quercetin 3-O-glucuronide |
11.02 | 18199750 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
11.02 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.50 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.50 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.64 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.67 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.13 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.26 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Deferoxamine |
2.09 | 15993339 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.09 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.09 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.19 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.68 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.47 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.47 | 15553829 16217749 11135700 14691202 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
4.47 | 19321006 16227395 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.44 | 16675471 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.72 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.98 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
4.91 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
4.91 | 18922899 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.28 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.37 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.49 | 10977129 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.03 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.76 | 15861022 16919318 17110522 17681005 11677210 16105132 17333356 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.04 | 8697196 16354765 15340226 12621046 15668235 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.98 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.43 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.59 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.59 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.66 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.04 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.42 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.42 | 10048152 15322242 20055451 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.95 | 15213294 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.64 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.63 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.83 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.41 | 11529661 11461765 15619225 10915739 16393943 16781746 2444490 11287661 19923254 11834606 10774834 15968718 16109766 12958197 14550746 16227642 12392966 19416960 19164858 14986274 11743745 19739265 17562736 18071297 11739529 17906064 12594235 11421492 16485898 14725611 19370779 12153990 12540782 16081117 19420014 16177239 18713872 17522070 10663392 19085960 12705907 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.41 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.95 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.65 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
4.79 | 16935035 |
MESH:D004487 |
Edema |
|
Furosemide |
20.23 | 11834646 |
MESH:D004487 |
Edema |
|
resveratrol |
20.23 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
20.23 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
20.23 | 8113982 9599246 7812673 15177302 8273558 11698051 16716910 |
MESH:D004487 |
Edema |
|
Zymosan |
20.23 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.75 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Am 80 |
14.71 | 16819260 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.71 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
14.71 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.89 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.24 | 17637181 15821434 15328337 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.70 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.27 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
7.28 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.28 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.31 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.88 | 11852909 9205823 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.80 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.11 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.52 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
3.83 | 16187019 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.44 | 10696789 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.70 | 17868369 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.25 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
3.97 | 16845234 12660669 16011733 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.25 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.20 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
4.55 | 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.74 | 15340226 16120746 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.03 | 16876885 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.89 | 16354765 8697196 18606429 15340226 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.58 | 16870215 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
4.93 | 17652376 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.50 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.87 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.89 | 16873680 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
5.72 | 15086907 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.85 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
5.13 | 16612254 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.17 | 17488730 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.50 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
5.72 | 16096441 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.66 | 16569931 16945680 |
MESH:D007022 |
Hypotension |
|
Furosemide |
4.47 | 11041285 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
5.27 | 15811171 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.50 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.32 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.39 | 17937319 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
15.07 | 12878042 9205823 17237260 17963957 17255318 |
MESH:D007249 |
Inflammation |
|
resveratrol |
15.07 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.07 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
15.07 | 11698051 7812673 7562506 8273558 15177302 |
MESH:D007249 |
Inflammation |
|
Zymosan |
15.07 | 8014878 11289658 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.39 | 16624496 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.49 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.68 | 17553498 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.20 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.03 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
6.03 | 11041285 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.76 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.66 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.15 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.32 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.62 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
4.32 | 17050201 20471514 16467208 19850784 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Deferoxamine |
4.32 | 20368581 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Am 80 |
12.41 | 16819260 16531727 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
12.41 | 12712474 16823087 9834237 16891316 19225113 17649720 16966277 16112521 15336539 19642359 12018890 17107899 15748426 15213294 16331271 17712046 11161223 19035177 12679006 19075265 16330433 11468182 17869043 15622746 17217047 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
12.41 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.20 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.55 | 15821434 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
1,3-dimethylthiourea |
3.65 | 11682029 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
3.65 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.65 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.59 | 12969438 16611625 19460945 11587558 19784758 12587719 19014921 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.10 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.14 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
7.14 | 19812893 19073162 20405173 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.14 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
5.49 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.49 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.23 | 15213294 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.86 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.38 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.38 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
3.38 | 11807781 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.16 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.75 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.09 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
6.12 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
6.12 | 8985016 |
MESH:D008545 |
Melanoma |
|
Carmustine |
3.72 | 12393984 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.72 | 17992120 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.42 | 19513568 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.24 | 17112576 |
MESH:D009101 |
Multiple Myeloma |
|
Am 80 |
11.72 | 17229644 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
11.72 | 19417148 11468182 14977855 19549372 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
11.72 | 17935668 17049120 17164350 14749477 16267019 16490592 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
5.06 | 12130978 15213630 17724436 15259001 15241586 10890648 18160304 12879239 10479408 15834315 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.72 | 17962980 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.52 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.06 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
2.97 | 17188708 17015251 17125593 16317513 16525036 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.61 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.61 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.61 | 17322642 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.81 | 16624393 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.85 | 8985016 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
5.72 | 15086907 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.76 | 17356569 15790535 18619942 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.07 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.02 | 10525206 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.94 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.94 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.26 | 17929310 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
5.72 | 17945291 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.11 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.36 | 16624393 19769630 12452020 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.27 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.35 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
5.35 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.54 | 11578682 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.14 | 18922899 8330346 12065085 18404319 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.02 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
2.92 | 11445065 18191903 11535288 18619942 16140633 19232380 19114014 16412576 15451049 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.94 | 15927086 15574749 15795934 18197244 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.10 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.73 | 19641140 14761945 17826846 18760300 17371808 18977430 15259001 15979727 18557954 11985352 19088179 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.40 | 12224865 11605937 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.50 | 17945291 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.41 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
9.08 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.08 | 11896295 11399792 11118676 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 16998812 |
MESH:D011471 |
Prostatic Neoplasms |
|
Am 80 |
2.87 | 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.87 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.87 | 17636462 17718901 17804756 17675339 15767336 16731767 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.16 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Am 80 |
4.04 | 16819260 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.43 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
6.89 | 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.89 | 16314181 16317513 17520802 17058453 15827377 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
4.47 | 12394941 15912074 16096441 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.63 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.81 | 16646077 |
MESH:D018805 |
Sepsis |
|
Zymosan |
4.52 | 11441115 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
13.03 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.03 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.03 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
13.03 | 18404319 11807781 8330346 12065085 8985016 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.79 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.81 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
2.81 | 17052386 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.35 | 16321402 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.03 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.48 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.02 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.75 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
2.97 | 19014326 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.08 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.81 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
2.42 | 12845720 20435036 12973940 11780464 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.83 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
3.97 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.01 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
9.01 | 17044934 |
MESH:D014605 |
Uveitis |
|
Zymosan |
5.25 | 11006244 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.44 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.15 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.10 | 15886252 |